Mattoussi also has a grant agreement with Pfizer, the world's largest pharmaceutical company, to use QD nanoprobes to visualize and probe the body's blood-brain barrier, which protects the brain from many types of infections but can also make it difficult to diagnose and treat various brain disorders.